GlaxoSmithkline Pharma drops ex-dividend

Meanwhile, the S&P BSE Sensex was down 133.13 points or 0.71% at 18,668.51.

On BSE, 835 shares were traded in the counter as against average daily volume of 7,477 shares in the past one quarter.

The stock hit a high of Rs 2,236 and a low of Rs 2,207.10 so far during the day. The stock had hit a 52-week low of Rs 1,916 on 4 July 2012. The stock had hit a record high of Rs 2,520 on 22 February 2013.

The stock had outperformed the market over the past one month till 3 April 2013, surging 7.67% compared with the Sensex's 0.62% fall. The scrip had also outperformed the market in past one quarter, jumping 5.13% as against Sensex's 4.87% fall.

The large-cap pharmaceutical company has equity capital of Rs 84.70 crore. Face value per share is Rs 10.

Before turning ex-dividend, the stock offered a dividend yield of 2.22% based on the closing price of Rs 2252.20 on Wednesday, 3 April 2013.

GlaxoSmithkline Pharmaceuticals' net profit rose 1.3% to Rs 138.51 crore on 16% growth in net sales to Rs 656.69 crore in Q4 December 2012 over Q4 December 2011.

GlaxoSmithkline Pharmaceuticals is engaged in manufacturing and marketing pharmaceutical and healthcare products such as betamethasone, cefuroxime and ranitidine.

Powered by Capital Market - Live News